Guru Fundamental Report for PG

Validea's analysis indicates Procter & Gamble (PG) scored 88% on its P/B Growth Investor model, a quantitative strategy developed by Partha Mohanram to identify low book-to-market stocks with sustained growth potential. As a large-cap stock in the Personal & Household Products industry, PG passed most of the model's fundamental criteria, including return on assets and cash flow from operations, though it notably failed the research and development to assets test. This rating suggests significant interest in PG's underlying fundamentals and valuation as a potential growth investment.

Analysis

Procter & Gamble (PG) demonstrates strong fundamental characteristics according to Validea's P/B Growth Investor model, achieving a score of 88%. This quantitative strategy, developed by academic Partha Mohanram, is designed to identify low book-to-market stocks with potential for sustained future growth. PG passed eight of the nine core criteria, signaling robust operational health through its solid Return on Assets (ROA), high Cash Flow from Operations to Assets, and stability in both ROA and sales variance. The company also meets the model's thresholds for advertising and capital expenditures relative to its asset base. However, the analysis flags a notable weakness, as PG fails the test for Research and Development to Assets, suggesting its R&D investment may be suboptimal according to the model's specific criteria for a high-growth company.

Key Decisions for Investors

• Given the strong positive sentiment and high score on a quantitative growth model, investors may find PG's profile compelling as a quality growth holding that exhibits operational efficiency.
• The identified failure in the Research and Development to Assets metric warrants further due diligence; investors should assess if PG's innovation pipeline is sufficient to sustain long-term growth despite the lower R&D spend highlighted by the model.
• Investors should monitor PG's capital allocation, specifically watching for any changes in R&D spending trends, as this is the primary weak point identified by an otherwise very positive fundamental screen.